Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,992 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chondroprotective Properties of Human-Enriched Serum Following Polyphenol Extract Absorption: Results from an Exploratory Clinical Trial.
Wauquier F, Mevel E, Krisa S, Richard T, Valls J, Hornedo-Ortega R, Granel H, Boutin-Wittrant L, Urban N, Berger J, Descamps S, Guicheux J, Vinatier CS, Beck L, Meunier N, Blot A, Wittrant Y. Wauquier F, et al. Among authors: berger j. Nutrients. 2019 Dec 16;11(12):3071. doi: 10.3390/nu11123071. Nutrients. 2019. PMID: 31888255 Free PMC article. Clinical Trial.
Bone marrow hematons: An access point to the human hematopoietic niche.
Janel A, Berger J, Bourgne C, Lemal R, Boiret-Dupré N, Dubois-Galopin F, Déchelotte P, Bothorel C, Hermet E, Chabi S, Bay JO, Lambert C, Pereira B, Pflumio F, Haddad R, Berger MG. Janel A, et al. Among authors: berger j, berger mg. Am J Hematol. 2017 Oct;92(10):1020-1031. doi: 10.1002/ajh.24830. Epub 2017 Jul 29. Am J Hematol. 2017. PMID: 28639326 Free article.
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34- and immature CD34+ cells.
Berger MG, Lebecque B, Tassin T, Dannus LT, Berger J, Soucal M, Guerci A, Cony-Makhoul P, Johnson H, Etienne G, Guyotat D, Gagnieu MC, Pereira B, Saugues S, Tournilhac O, Hermet E, Bourgne C. Berger MG, et al. Among authors: berger j. Sci Rep. 2021 Mar 17;11(1):6187. doi: 10.1038/s41598-021-85734-0. Sci Rep. 2021. PMID: 33731863 Free PMC article.
The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.
Janel A, Dubois-Galopin F, Bourgne C, Berger J, Tarte K, Boiret-Dupré N, Boisgard S, Verrelle P, Déchelotte P, Tournilhac O, Berger MG. Janel A, et al. Among authors: berger j, berger mg. Stem Cells Dev. 2014 Dec 15;23(24):2972-82. doi: 10.1089/scd.2014.0229. Stem Cells Dev. 2014. PMID: 25055118
A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease.
Tebani A, Mauhin W, Abily-Donval L, Lesueur C, Berger MG, Nadjar Y, Berger J, Benveniste O, Lamari F, Laforêt P, Noel E, Marret S, Lidove O, Bekri S. Tebani A, et al. Among authors: berger mg, berger j. J Clin Med. 2020 May 2;9(5):1325. doi: 10.3390/jcm9051325. J Clin Med. 2020. PMID: 32370284 Free PMC article.
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia.
Lebecque B, Bourgne C, Munje C, Berger J, Tassin T, Cony-Makhoul P, Guerci-Bresler A, Johnson-Ansah H, Liu W, Saugues S, Tchirkov A, Vetrie D, Copland M, Berger MG. Lebecque B, et al. Among authors: berger j, berger mg. Cancers (Basel). 2022 Sep 27;14(19):4695. doi: 10.3390/cancers14194695. Cancers (Basel). 2022. PMID: 36230624 Free PMC article.
3,992 results